BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 9723658)

  • 1. Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects.
    Hamilton A; Faiferman I; Stober P; Watson RM; O'Byrne PM
    J Allergy Clin Immunol; 1998 Aug; 102(2):177-83. PubMed ID: 9723658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005.
    Hamilton AL; Watson RM; Wyile G; O'Byrne PM
    Thorax; 1997 Apr; 52(4):348-54. PubMed ID: 9196518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role for cysteinyl leukotrienes in allergen-induced change in circulating dendritic cell number in asthma.
    Parameswaran K; Liang H; Fanat A; Watson R; Snider DP; O'Byrne PM
    J Allergy Clin Immunol; 2004 Jul; 114(1):73-9. PubMed ID: 15241347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma.
    Nakamura Y; Hoshino M; Sim JJ; Ishii K; Hosaka K; Sakamoto T
    Thorax; 1998 Oct; 53(10):835-41. PubMed ID: 10193369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of leukotriene receptor antagonist in bronchial hyperresponsiveness and hypersensitivity to analgesic in aspirin-intolerant asthma.
    Yoshida S; Sakamoto H; Ishizaki Y; Onuma K; Shoji T; Nakagawa H; Hasegawa H; Nakabayashi M; Amayasu H
    Clin Exp Allergy; 2000 Jan; 30(1):64-70. PubMed ID: 10606932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bimosiamose, an inhaled small-molecule pan-selectin antagonist, attenuates late asthmatic reactions following allergen challenge in mild asthmatics: a randomized, double-blind, placebo-controlled clinical cross-over-trial.
    Beeh KM; Beier J; Meyer M; Buhl R; Zahlten R; Wolff G
    Pulm Pharmacol Ther; 2006; 19(4):233-41. PubMed ID: 16140027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo.
    Diamant Z; Timmers MC; van der Veen H; Friedman BS; De Smet M; Depré M; Hilliard D; Bel EH; Sterk PJ
    J Allergy Clin Immunol; 1995 Jan; 95(1 Pt 1):42-51. PubMed ID: 7822663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pranlukast, an oral leukotriene receptor antagonist, on leukotriene D4 (LTD4) challenge in normal volunteers.
    O'Shaughnessy TC; Georgiou P; Howland K; Dennis M; Compton CH; Barnes NC
    Thorax; 1997 Jun; 52(6):519-22. PubMed ID: 9227717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma.
    Barnes NC; Pujet JC
    Thorax; 1997 Jun; 52(6):523-7. PubMed ID: 9227718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a cysteinyl leukotriene antagonist, pranlukast hydrate, on acetaldehyde-induced bronchoconstriction in asthmatic patients.
    Myou S; Fujimura M; Kamio Y; Kita T; Katayama N; Abo M; Yoshimi Y; Nishitsuji M; Nomura S; Hashimoto T; Nakao S
    Prostaglandins Leukot Essent Fatty Acids; 2001 Jul; 65(1):41-4. PubMed ID: 11487307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma.
    Diamant Z; Grootendorst DC; Veselic-Charvat M; Timmers MC; De Smet M; Leff JA; Seidenberg BC; Zwinderman AH; Peszek I; Sterk PJ
    Clin Exp Allergy; 1999 Jan; 29(1):42-51. PubMed ID: 10051701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pranlukast on bronchial inflammation in patients with asthma.
    Yoshida S; Ishizaki Y; Shoji T; Onuma K; Nakagawa H; Nakabayashi M; Akahori K; Hasegawa H; Amayasu H
    Clin Exp Allergy; 2000 Jul; 30(7):1008-14. PubMed ID: 10848924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of fluticasone and montelukast on allergen-induced asthma.
    Palmqvist M; Bruce C; Sjöstrand M; Arvidsson P; Lötvall J
    Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of fluticasone on allergen-induced airway responses and sputum inflammatory markers.
    Parameswaran K; Inman MD; Watson RM; Morris MM; Efthimiadis A; Ventresca PG; Lam R; O'Byrne PM; Hargreave FE
    Can Respir J; 2000; 7(4):313-9. PubMed ID: 10980457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of a leukotriene antagonist, pranlukast hydrate, on exercise-induced asthma for 14 days].
    Suguro H; Majima T; Hattori T; Ichimura K; Hashimoto N; Horie T
    Arerugi; 2000 Aug; 49(8):646-52. PubMed ID: 11021016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of pranlukast on allergen-induced bone marrow eosinophilopoiesis in subjects with asthma.
    Parameswaran K; Watson R; Gauvreau GM; Sehmi R; O'Byrne PM
    Am J Respir Crit Care Med; 2004 Apr; 169(8):915-20. PubMed ID: 14742305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma.
    Norris V; Choong L; Tran D; Corden Z; Boyce M; Arshad H; Holgate S; O'Connor B; Millet S; Miller B; Rohatagi S; Kirkesseli S
    J Allergy Clin Immunol; 2005 Oct; 116(4):761-7. PubMed ID: 16210048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dual CysLT
    Gauvreau GM; Boulet LP; FitzGerald JM; Cockcroft DW; Davis BE; Leigh R; Tanaka M; Fourre JA; Tanaka M; Nabata T; O'Byrne PM
    Allergy; 2016 Dec; 71(12):1721-1727. PubMed ID: 27444660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of a CCR3 inhibitor, AXP1275, on allergen-induced airway responses in adults with mild-to-moderate atopic asthma.
    Gauvreau GM; FitzGerald JM; Boulet LP; Watson RM; Hui L; Villineuve H; Scime TX; Schlatman AR; Obminski C; Kum J; Boehme S; Ly TW; Bacon KB; O'Byrne PM
    Clin Exp Allergy; 2018 Apr; 48(4):445-451. PubMed ID: 29423947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of single-dose inhaled corticosteroid activity with an allergen challenge model.
    Kidney JC; Boulet LP; Hargreave FE; Deschesnes F; Swystun VA; O'Byrne PM; Choudry N; Morris MM; Jennings B; Andersson N; Andreasson A; Cockcroft DW
    J Allergy Clin Immunol; 1997 Jul; 100(1):65-70. PubMed ID: 9257789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.